Form 4: Vor Biopharma Director Lubner Acquires Stock Options

Director David Charles Lubner acquired stock options for 30,000 shares of Vor Biopharma Inc. at an exercise price of $1.61 on May 23, 2024.

Summary

• On May 23, 2024, David Charles Lubner, a director of Vor Biopharma Inc., was granted stock options to purchase 30,000 shares of common stock.
• The exercise price of these options is $1.61 per share.
• The options vest on the earlier of May 23, 2025, or the date of the next annual meeting of stockholders, contingent upon continued service as a director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and aligns the director's interests with those of the shareholders. There are no immediate negative implications.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The director's continued service is incentivized by the vesting schedule of the stock options.

Industry Context

Granting stock options to directors is a common practice in the biopharmaceutical industry to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Stock option grants to board members are a standard component of compensation packages in the biotech industry, often benchmarked against peer companies of similar market capitalization and stage of development.
• Companies like CRISPR Therapeutics and Editas Medicine also utilize stock options as part of their director compensation, with vesting schedules typically tied to continued service and company performance.
• The size of the grant, 30,000 shares, and the exercise price of $1.61 would need to be compared to similar grants at comparable companies to assess its relative value.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to contribute to the company's growth and value creation.

Key Dates